Affidea Group is continuing expansion across Europe after securing an additional €200 million fungible term loan B and repricing its debt structure.
The company highlighted its expansion in early 2024 that included three acquisitions in Italy, Spain, and Romania, as well as two greenfields in Portugal and Switzerland, said Guy Blomfield, Affidea CEO and chairman of the management board, in a statement. In 2023, Affidea completed 14 acquisitions across eight countries, including Switzerland, the U.K., Spain, Portugal, Italy, and Romania, and expanded in Lithuania, Poland, Romania, and Greece.
Affidea, which focuses on outpatient services, lab services, and cancer care, now operates 355 centers in 15 countries. The latest credit facility adds to an existing €770 million term loan B, the company said.
BNP Paribas, Goldman Sachs, and KKR jointly arranged the new credit facility with Citi, Unicredit, and RBI. Affidea is majority-owned by Groupe Bruxelles Lambert.
